Session: Neuropathogenesis: Clinical Correlates and Observational Studies

Home

Session 75 Poster Abstracts
Neuropathogenesis: Clinical Correlates and Observational Studies
Tuesday, 1:30 - 3:30 pm
Poster Hall


499	Presence of Nucleotide Excision Resistance Mutations in Cerebrospinal Fluid Is Associated with Reduced Prevalence of HIV-Related Brain Lesions C Pierotti¹, M Nebuloni², A Bestetti¹, S Presi¹, M R Terreni¹, S E Sala¹, S T Sala¹, P Carrera¹, A Lazzarin¹, L Vago², and P Cinque¹ ¹San Raffaele Hosp., Milan, Italy and ²Luigi Sacco Hosp., Milan, Italy*
500	MCP-1 and HIV Viral Load Dynamics in Cerebrospinal Fluid and Plasma are linked in AIDS Patients Changing Antiretroviral Therapy S de Almeida¹, S Letendre², J Zimmerman², D Lazzaretto², R Ellis², and HIV Neurobehavioral Research Center ¹UFPR, Curitiba, Parana, Brazil and ²Univ. of California, San Diego, USA*
501	Neurological Functioning and CNS Penetrating Antiretroviral Regimens K Robertson, W Robertson, S Ford, A Harp, and C Hall Univ. of North Carolina at Chapel Hill, USA*
502	Diabetes and Cognitive Functioning Among HIV Seropositive Patients. The Hawaii Aging with HIV Cohort V Valcour¹, C Shikuma¹, B Shiramizu¹, J Grove¹, M Watters¹, J Grove¹, M Watters¹, P Poff^1,2, O Selnes², and N Sacktor² ¹Univ. of Hawaii, Honolulu, USA and ²Johns Hopkins Univ., Baltimore, MD, USA*
503	CD14⁺/CD16⁺ Monocytes Are Enriched in Cerebrospinal Fluid Compared to Blood of HIV-1-infected Subjects, Especially during Successful ART J K Neuenburg^1,2, S Furlan¹, A Nilsson², R W Price², and RM Grant¹ ¹Gladstone Inst. of Virology and Immunology, Univ. of California, San Francisco, USA and ²Univ. of California, San Francisco, USA*
504	Early Brainstem Damage Is Predictive of Poor Survival in HIV-infected Patients with Progressive Multifocal Leukoencephalopathy J Gasnault^1,2, M G de Goer de Hervé², J Rahoiljaon¹, J-F Delfraissy^1,2, and Y Taoufik^1,2 ¹Hosp. Univ. de Bicetre, Le Kremlin Bicetre, France and ²INSERM E0109, Le Kremlin Bicetre, France*
505	Cerebrospinal Fluid HIV Concentration is Highly Associated with Blood CD8⁺ T Cell Activation and Antiretroviral Treatment Responses E Sinclair¹, R Ronquillo², M Bigos², A Nilsson¹, S Deeks¹, C Csajka¹, D Verotta¹, and R Price¹ ¹Univ. of California, San Francisco, USA and ²Gladstone Inst. Virology and Immunology, San Francisco, CA, USA*
506	Macrophage Chemotactic Protein Levels in Cerebrospinal Fluid of Patients with AIDS-associated PML Treated with HAART Favorably Correlate with Patients Survival A Marzocchetti¹, A Cingolani¹, S Di Giambenedetto¹, M L Giancola², A Antinori², and A De Luca¹ ¹Inst. di Clinica delle Malattie Infettive, Catholic Univ. of Sacro Cuore, Rome, Italy and ²Inst. Natl. delle Malattie Infettive, IRCCS "Lazzaro Spallanzani'', Rome, Italy*
507	Neurocognitive Impairment and Survival in HIV-Positive Patients Treated with HAART: Results from an Urban Observational Cohort V Tozzi, P Balestra, D Serraino, R Bellagamba, A Corpolongo, C Vlassi, P Piselli, U Visco-Comandini, M E Quartuccio, D Larussa, L Pucillo, N Petrosillo, G Ippolito, A Antinori, and P Narciso INMI L. Spallanzani, Rome, Italy*
508	Antiretroviral Drugs Penetrating CSF Do Not Influence Neurocognitive Performance in HIV-1 -infected Patients Responders to HAART A Antinori, P Balestra, M L Giancola, M E Quartuccio, D Larussa, P Lorenzini, F Baldini, A Corpolongo, R Bellagamba, and V Tozzi INMI Lazzaro Spallanzani IRCCS, Rome, Italy*